{
    "Trade/Device Name(s)": [
        "GlucoDr.S Blood Glucose Monitoring System",
        "GlucoDr.S BLE Blood Glucose Monitoring System",
        "GlucoDr.S NFC Blood Glucose Monitoring System"
    ],
    "Submitter Information": "All Medicus Co., Ltd.",
    "510(k) Number": "K170241",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083628"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "September 12, 2017",
    "Summary Letter Received Date": "September 15, 2017",
    "Submission Date": "October 12, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoDr.S Blood Glucose Meter",
        "GlucoDr.S BLE Blood Glucose Meter",
        "GlucoDr.S NFC Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Monitoring System",
        "Meter",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoDr.S, GlucoDr.S BLE, and GlucoDr.S NFC Blood Glucose Monitoring Systems for self-testing glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose (sugar) in fresh capillary whole blood from fingertip for self-testing by people with diabetes at home as an aid to monitor effectiveness of diabetes control; not for diagnosis or screening of diabetes or use in neonates.",
    "fda_folder": "Clinical Chemistry"
}